(September 1986). Eight FT clones were chosen at random for further study and the remaining five FT clones were frozen . The FT clones D11, H5, D5, H12, G12, E10, F1, and A2 have been maintained in culture with GFCM at the conditions indicated above.
Other Cell Lines. The LD1 Th line (23) , the EL-4 T lymphoma, and the T hybrid HK301 (obtained by fusing 15-d FT with BW5147 T lymphoma cells) (Pelkonen, J., unpublished results) were maintained in culture medium. The 2 .19 Th line (27) was maintained and expanded in culture medium supplemented with IL-2-containing supernatants and stimulation with x-ray irradiated C57BL/6 spleen cells as described (27) . The 4E7 T killer line that recognizes minor histocompatibility antigens in the context of H-2 'ẁ as derived from BALB/c spleen cells stimulated with BALB.K-irradiated spleen cells as described (28) .
Isolation and Analysis of Nucleic Acids. DNA and RNA preparation, restriction enzyme digestions, agarose gel electrophoresis, DNA blotting procedures, probe preparations, hybridization procedures, and autoradiography were performed as described (29, 30) .
y Gene Complex Probe. The Cy l cDNA probe (900-bp Ava I-Eco RI cDNA clone containing all the C-y1 coding region and its 3' untranslated region) (14) , the Jy 1 probe (1 .2-kb Ava I-Hind III genomic fragment) (30) , and the Cy2 probe (1 .0-kb Eco RI-Hind III genomic fragment (30) were used.
Gene Complex Probe. The 4.1 cDNA probe specific for the constant region of the S gene complex (11) , the pj#1 probe (Bam HI-Eco RI genomic fragment) (31, 32) , and the pjf2 probe (Cla I-Eco RI genomic fragment) (31, 32) were used.
a Gene Complex Probe. The a chain probe used is the 300-bp Nco I-Ava 11 fragment from the constant portion of the a chain cDNA clone T1 .2 (33) .
RNA-RNA In Situ Hybridization . The FT clones and the LD1 T cell line stimulated with PMA (10 ng/ml) and ionomycin (500 ng/ml) at 37°C for 2-4 h or unstimulated were assayed for the presence of mRNA for IL-4 by RNA-RNA in situ hybridization as described below and elsewhere (20) .
Cytocentrifuge Preparations . Glass slides were immersed in 70% ethanol and air dried . The cells suspended in balanced salt solution containing 10% FCS were loaded on glass slides (10 5 cells/slide) with the aid of a cytocentrifuge . The cell smears were fixed in paraformaldehyde (4% diluted in PBS) for 1 min, were transferred into a solution of 70% ethanol, and were subsequently stored at +4°C until used.
Preparation of the IL-4 Probe. The Rsa I-Rsa I fragment from the cDNA clone pSP6KmIL4-293 (26) containing all the coding sequence for IL-4 was subcloned into the gemini, SP6/T7 vectors. The pUC18 vector containing the Rsa I-Rsa I fragment was kindly provided by Dr. T. Honjo (Kyoto University, Kyoto, Japan) . Linearized plasmids were used as templates for the synthesis in vitro ofradioactive RNA probes complementary to the cellular IL-4 mRNA. RNA was also transcribed from the opposite direction (sense) and used as a negative control. -2 X 108 cpm were incorporated into RNA per microgram of RNA template . The size of the full-length probe mRNA was -400 nucleotides .
In Situ Hybridization. Fixed slides prepared as described above were rinsed twice in 2X SSC (20X SSC = 3 M NaCl, 0.3 M sodium citrate) and then acetylated (pH 8, 0.25% acetic anhydride) for 10 min. After this, the slides were rinsed in 2X SSC and PBS, then immersed in 0.1 M Tris-HCl, 0.1 M glycine, pH 7.0, for 30 min before hybridization . 20 jl of probe mixture (10 Al formamide-20% dextran sulfate, 2 Al sheared herringsperm DNA [10 mg/ml], 2 Al nuclease-free BSA [20 mg/ml], 1 j,1 labeled RNA [106 cpm/kl]) were loaded on each slide and hybridization was performed at 50°C for 3 h. The slides were washed three times with 50% formamide, 2X SSC at 52°C, rinsed in 2X SSC, and treated with 30 Al RNase solution for 30 min at 37°C (100 kg/ml RNase A plus 1 ug/ml RNase-T1) . The slides were rinsed twice in 2X SSC, once in 50% formamide, 2X SSC at 52°C, rinsed again three times in 2X SSC, were dehydrated in 70, 80, and 90% ethanol, respectively, were air dried, and finally were autoradiographed. Kodak nuclear track emulsion (NTB-2, Eastman Kodak Co., Rochester, NY) was melted at 43°C and diluted with an equal volume of water . The slides were dipped into the emulsion and allowed to solidify horizontally at room temperature for 3-4 h. The emulsion-coated slides were kept at +4°C for 3-5 d for exposure. The slides were developed in Kodak developer-19 at +15°C for 5 min. After a rinse in tap water the fixation was carried out in Kodak fixer for 5 min and the slides were washed with water for 30 min. The slides were stained with 10% Giemsa stain for 2.5 min, washed twice with tap water, and were air dried. We considered as positive cells (cells expressing IL-4-mRNA) those cells that had >10 grains per cell. Elsewhere (20) we have shown that (a) cold IL-4-RNA synthesized in the sense orientation inhibits the binding ofthe radioactive probe to the cellular mRNA, and (b) no hybridization is observed either when the cytocentrifuge preparations are pretreated with RNase or when RNA probes synthesized in the wrong orientation are used (20) , demonstrating the validity and specificity of the technique for the detection of IL-4-mRNA .
Immunofuorescence Staining and Flow Cytometry Analysis (FACS) . This procedure was carried out as described in detail before (10, 22) using FITC-conjugated anti-mouse Ig, anti-rat Ig, and anti-hamster Ig as second-step reagents. Dead cells were excluded from analysis by using propidium iodide. The fluorescence emitted by single viable cells was measured using logarithmic amplification and the data collected from 10' cells were analyzed with a program in a Consort 30 computer and histograms were generated .
Proliferative Responses to Cytokines. The cells were harvested in logphase of growth, washed three times, and resuspended in culture medium . The cells (10) were incubated in microculture wells in a final volume of 200 Al of culture medium containing the following agents : rIL-1 (5-50 U/ml), rIL-2 (10-500 U/ml), rIL-4 (final dilutions, 1 :4 to 1 :256), PMA (10 ng/ml), or the combination of PMA + rIL-2 (100 U/ml). The cultures in triplicate were incubated at 37°C for 24 and 48 h. Cell growth was measured by both direct visualization of the cultures with an inverted microscope and ['Hlthymidine uptake (37 KBq/well) during the last 5-6 h of the culture period . The data are expressed as counts per minute and are the mean of triplicate samples .
Helper and Cytotoxic T Cell Functions. The capacity of the FT clones to assist T celldepleted spleen B cells from CBA/J mice to generate antibody-secreting cells was studied in a Con A-facilitated microculture assay as detailed before (23) . The number of antibodysecreting cells was determined by the reverse hemolytic protein A plaque assay after 5 d of culture at 37°C. The results are expressed as PFC per culture and are the mean of duplicate cultures.
The capacity of the FT clones to exert cytolytic activity was tested in a PHA-facilitated microcytotoxicity assay using as target cells "Cr-labeled LPS-stimulated spleen cells from CBA/J and DBA/2 mice or EL-4 T lymphoma cells and were performed as described (28) . The results are expressed as percent of specific "Cr release .
Results

Establishment in Culture of FT Clones
Single FT from 14-d embryonic thymus of B10 .BR mice were placed in microculture wells by micromanipulation and the cultures were supplemented with GFCM . 13 independently isolated clones were established out of 172 cultures as detailed in experimental procedures . Eight clones, called FT D11, FT H5, FT D5, FT G12, FT H12, FT E10, FT F1, and FT A2, were chosen at random for further study and the other five clones were frozen . The FT clones were established in September 1986 and maintained in culture up to present by culturing them in fresh GFCM every 2 d.
Configuration and Expression of the TCR--y, -#, and -a Genes
The eight FT clones chosen for further study were expanded and analyzed for the expression of the TCR-y, -f, and -a genes and surface phenotype .
The expression of mRNA for TCR-y, -fl, and -a genes in the FT clones was studied by Northern blot analysis . The results show that all FT clones have mRNA for the y gene and that none of them contain detectable mRNA for the TCR-# or -a genes (Fig. 1) .
Next, we assessed the configuration of the TCR genes in the FT clones by Southern blot analysis . The state of the y l , y3, and y4 gene clusters (the nomenclature for the y gene clusters is that proposed by Traunecker et al .
[311) was assessed using the PJy 1 probe and Hind III-digested DNAs from liver and the FT clones. This analysis shows that all eight clones contain the 71 and the y4 genes in germline configuration (Fig. 2C) and that the B10 .BR mouse strain like other mice (DBA/2, B10.A, CBA/J) do not have the y3 pseudogene (Fig. 2C) . No evidence for rearrangement of the y2 gene cluster was found using the Cy2-specific probe and Eco RI-digested DNAs (not shown) .
Using probes specific for the Jal and the J,B2 regions, respectively, and Eco RI-digested DNAs we found that all eight FT clones contain both the al ( Fig.   2A ) and the (32 ( Fig. 2B ) genes in germline configuration . Due to the long distance spanning the Ja chromosomal region, the presence of rearrangements of the TCR-a gene is more difficult to determine. We are in the process of generating genomic probes that will cover the^-60-kb Ja chromosomal region to be able to detect TCR-a gene rearrangements .
Surface Phenotype
The phenotype of the FT clones was determined by immunofluorescence staining and FACS using a panel of mAbs against cells of the T cell, B cell, and myeloid cell lineages . Three distinct phenotypes were found .
Phenotype I. The FT clones E10, Fl, D5, and H5 express Thy-1, Ly-1, Lyt-2, Pgp-1, and IL-2-R but no detectable L3T4 or T3 surface molecules (Fig. 3) .
Phenotype IL. The FT clones A2 and G12 resemble the FT clones with phenotype I except that they do not express detectable IL-2-R as assessed with the two anti-IL-2-R mAbs 7D4 (Fig. 3) and PC61 (not shown) .
Phenotype III . The FT D 11 and FT H 12 clones differ from the FT clones with phenotypes I and II in that they express L3T4 (Fig. 3) .
None of the eight FT clones have detectable IgM, la, B-220, or Mac-1 molecules on the cell membrane, and all of them are H-2k+ and LFA-1 +.
Growth Requirements
The next set of experiments was designed to define the growth factors used by the FT clones to continuously proliferate in vitro . All eight FT clones grow in rIL-4 but not in rIL-1 . All six IL-2-R+ FT clones also proliferate in rIL-2, albeit to a lesser extent than in IL-4 ( Table I ). The FT clones A2 and G12 do not express receptors for IL-2 (Fig. 3) . However, both FT A2 and FT G12 clones can be induced to express IL-2-R (assessed by FACS analysis with 7D4 and PC61 mAbs) by treating them with PMA (not shown), and the PMA-treated A2 and G12 FT clones proliferate in rIL-2 (Table I) . PMA by itself is not mitogenic on the FT clones.
The PC61 and 7D4 anti-IL-2-R antibodies strongly inhibited the action of rIL-2 on the FT clones but did not significantly affect the action of rIL-4 (Fig. 4) indicating that IL-4 promotes growth of the FT clones via an IL-2-independent pathway . These results show that the FT clones can use both IL-4 and IL-2 as * The FT clones indicated above were cultured in medium containing AL-1 (20 U/ml), rIL-2 (100 U/ml), rIL-4 (final dilution 1:16), PMA (10 ng/ml) or PMA + rIL-2, at 37°C for 24 h. Cell proliferation was assessed by ['H]thymidine uptake during the last 5 h of the culture period . t The FT clones A2 and G12, unlike the other FT clones, do not express IL-2-R . PMA induces both A2 and G12 cells to express IL-2-R as determined by FACS analysis using 7D4 or PC61 mAbs specific for IL-2-R . growth factors in vitro. The FT clones self-renew in vitro in rIL-4 every 10-14 h and die within 48-72 h in the absence of exogenous growth factors.
Functions The FT clones were tested for three T cell functions : help to B lymphocytes, cytolytic activity, and synthesis of IL-4.
We studied whether the FT clones synthesize IL-4. This was of particular interest in light of our previous work (20) showing that 1 of 10 FT at day 14 of gestation synthesize mRNA for IL-4 after stimulation with PMA plus ionomycin, as assessed by RNA-RNA in situ hybridization . Thus the FT clones stimulated with PMA + ionomycin at 37'C for 2-4 h or unstimulated were assayed for the presence of mRNA for IL-4 by RNA-RNA in situ hybridization . The LD1 T cell line was included in these experiments and served as a negative control . We found that all eight FT clones synthesized IL-4-mRNA after stimulation by PMA + ionomycin . No IL-4-mRNA was detected in the unstimulated FT clones or in the stimulated LD 1 T cells (negative control) . No hybridization to the cellular RNA from stimulated FT clones was observed using radiolabeled probe synthesized in the wrong orientation (not shown) . The amount ofIL-4-mRNA produced by each clone (as judged by the number of grains counted per cell) varied among the FT clones, with clones A2, G12, and F1 producing the highest and clone H5 the lowest amount of IL-4-mRNA (Fig . 5) .
We were confronted with technical drawbacks to assess in biological assays the production of IL-4 by the FT clones . While supernatants from PMA + ionomycin-stimulated FT clones supported proliferation of cells known to respond to IL-4 (e.g ., C4-86 [10] , HT-2, freshly isolated FT), we could neither rule out the contribution of PMA + ionomycin in the responses nor ascertain that the growthpromoting activity in such responses was due to IL-4 (the target cells can respond to other growth factors, e.g., IL-2, IL-3) . Also, the presence ofPMA + ionomycin in the supernatants made it very difficult to test them for IgGI-inducing activity on LPS-stimulated B cells, as the drugs inhibited such responses .
The capacity of the FT clones to assist B lymphocytes to mature into antibodysecreting cells was determined on a Con A-facilitated microculture assay that reveals Th activity for B cells regardless of the specificity of the effector and target cells (23) . A Th line (LD1) was included in these experiments and served as positive control . The number of antibody-secreting cells (PFC) was determined by the protein A plaque assay after 5 d of culture at 37°C. We found that while the LD 1 T cell line assisted B lymphocytes to generate antibody-secreting cells, none of the eight FT clones at the various concentrations tested exhibited this function (data not shown) .
All FT clones were tested for cytolytic activity on "Cr-labeled target cells (LPS-activated syngeneic and allogeneic spleen cells or EL-4 T lymphoma cells) in a lectin-facilitated microcytotoxicity assay that reveals cytotoxic function regardless of the specificity of the effector cells. A T killer cell line (4E7) was included in the experiments as a positive control. None of the FT clones exert killer activity, whereas the 4E7 T cell line (positive control) efficiently killed the target cells (data not shown) .
Discussion
We have studied the molecular, cellular, and functional properties of the FT clones (1311, H5, D5, H12, G12, E10, F1, and A2) isolated from the thymus of a 14-d-old B10.BR mouse fetus.
The FT clones express mRNA for the -y chain gene, but no evidence for rearrangements of any of the 7 genes was found. The expression of germline transcripts for the 'Y gene in the FT clones could reflect the accessibility of the chromatin to recombinases as proposed for the germline transcripts for the Ig heavy chain gene found in early B cell precursor lines (34) . The finding that 1 d later in ontogeny (day 15 of gestation), FT with rearranged 'r gene clusters are often found (11-13 ; Pelkonen, J., unpublished results) is consistent with this view.
The FT clones have neither rearranged the TCR-,Q gene nor do they express detectable mRNA for either the TCR-a or -,8 genes, indicating that they are at a very early stage of development. The rearrangement of the ,Q genes is often detected at day 15 of gestation (11, 13, 15) . The FT clones express the L3T4 and/or the Lyt-2 T cell differentiation antigens . It probably reflects the effect of IL-4 on the FT clones as we previously found (19) with heterogeneous populations of FT that rIL-4 induces some of these cells to express Lyt-2. The failure to detect L3T4+ cells in such studies could be due to the sensitivity of the FAGS analysis coupled to the lower frequency of cells induced to express L3T4 by IL-4 (2 of 10 FT clones analyzed) and to the constant exposure of the cells to PMA. PMA may inhibit the expression of L3T4 by FT cultured in vitro (Palacios, R., unpublished observations). The data obtained here with the FT clones show that the expression of the L3T4 and Lyt-2 surface molecules can precede that of the TCR-a, -,B/T3 complex on the cell membrane. Experiments to be reported elsewhere (Palacios, R., and J. Pelkonen, manuscript in preparation) showed that the FT clones with phenotypes I and II (Lyt-2+, L3T4") can give rise to Lyt-2+, L3T4+ thymocytes carrying a,#/T3 T cell antigen receptor on the cell membrane . Thus, during ontogeny, the expression of the Lyt-2 molecule appears to precede that of the L3T4 surface antigen . This view is consistent with the finding that in vivo Lyt-2+, L3T4-FT are found before Lyt-2+, L3T4+, or Lyt-2-, L3T4+ thymocytes can be observed (35, 36) .
The FT clones grow in rIL-4, which acts on these cells via an IL-2-independent pathway. Six FT clones also proliferate in rIL-2, albeit to a lesser extent than in rIL-4. Interestingly, the FT clones A2 and G12 do not have receptors for IL-2 but PMA induces both clones to express functional receptors for IL-2. Thus, the FT clones A2 and G12 resemble a subpopulation of freshly isolated FT (~30-50%) that can be induced with PMA to express IL-2-R (37, and Palacios, R., unpublished observations). The finding that the FT clones respond to both IL-2 and IL-4 suggests that single FT can use both interleukins as growth factor .
While the FT clones have not yet reached the stage to exhibit either helper function for B lymphocytes or cytolytic activity, they are already able to synthesize mRNA for IL-4 after stimulation in vitro. The latter functional property resembles that of freshly isolated 14-d fetal thymocytes (20) and strengthens the possible role of IL-4 in the process of T cell development within the thymus .
The FT clones should prove valuable to address the questions as to what determines that a given precursor gives rise to T cells that recognize antigen in the context of either class I or class II MHC products, whether a single precursor can generate both T cells having TCR made of a,f/T3 complex and T cells carrying TCR y/T3 complexes on the cell membrane, and to study the regulation of the expression of the TCR-y, -#, and -a genes.
Summary
We have established in culture 13 clones from the thymus of a 14-d B10.BR mouse embryo and characterized 8 of them . All eight FT clones have the TCRy and -,8 genes in germline configuration . They express mRNA for the y, but not for the Q nor the a genes. All eight FT clones are Thy-1 +, Ly-1 +, LFA-1 +, Pgp-1 +, H-2K+, and T3-. Three phenotypes could be distinguished on the basis of Lyt-2, L3T4, and IL-2-R expression : Lyt-2+, L3T4-, IL-2-R' (1); Lyt-2', L3T4 -, IL-2-R-(II) ; and Lyt-2', L3T4+, IL-2-R+ (III) cells. All eight clones grow in rIL-4 and six clones also proliferate in rIL-2. Antibodies specific for IL-2-R inhibit their response to rIL-2 but not to rIL-4 . The eight FT clones synthesize mRNA for IL-4 after stimulation in vitro and none of them exhibit cytolytic activity or helper function for B lymphocytes. We conclude that the FT clones are at a very early stage of T cell development, that the expression of Lyt-2 and L3T4 surface molecules can precede that of the antigen receptor, and that the same fetal thymocyte can use both IL-4 and IL-2 as growth factor .
